The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

CompletedOBSERVATIONAL
Enrollment

1,651

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
Healthy PeopleBenign Prostatic HyperplasiaProstate Cancer
Interventions
DIAGNOSTIC_TEST

Multi-modal artificial intelligence model (BEAM)

Data from mpMRI and cfDNA analysis will be integrated and processed by deep learning. The model's output will be compared against the final pathological diagnosis from the prostate biopsy to evaluate its performance.

Trial Locations (10)

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

200433

Changhai Hospital, Shanghai

201209

Shanghai Changzheng Hospital, Shanghai

210029

Jiangsu Provincial People's Hospita, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

225001

Northern Jiangsu People's Hospita, Yangzhou

315010

Ningbo No. 1 Hospita, Ningbo

510120

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

610041

West China Hospital, Sichuan University, Chengdu

Unknown

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors
collaborator

Ningbo No. 1 Hospital

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Jiangsu Provincial People's Hospital

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Zhongda Hospital

OTHER

collaborator

Northern Jiangsu People's Hospital

OTHER

collaborator

Changhai Hospital

OTHER

collaborator

West China Hospital

OTHER

lead

Shanghai Changzheng Hospital

OTHER

NCT06589154 - The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis | Biotech Hunter | Biotech Hunter